fashion -WSS

fashion

author：hotspot 2025-09-29 10:31:31 - browse：1243

A heart monitoring watch, referred as Project Zero 2.0 is displayed in the Omron Healthcare booth during a press event – health tech coverage from STAT — Digital tools to better track blood pressure over time and encourage adherence to treatment plans are increasingly commonplace. David Becker/Getty Images

If you have high blood pressure, it’s increasingly likely that your doctor or your insurer will offer you a blood pressure cuff or an educational app to help you get it under control. While potentially impactful, these tools may not be reaching marginalized people who don’t regularly have access to good health care — and who may benefit the most from the tools.

A new analysis suggests that there ought to be more investment in novel hypertension programs for people experiencing health disparities.The meta-review of 28 studies of digital health interventions for people of color and low-income patients found that as a whole participants saw a statistically significant and clinically meaningful reduction in average systolic blood pressure compared to control groups. In total, the analysis included more than 8,000 participants; most of the studies followed participants for six or 12 months. The results, published Wednesday in JAMA Network Open, are consistent with studies of digital tools in the general population.

Joseph Ebinger, of the Smidt Heart Institute at Cedars-Sinai in Los Angeles, who was not involved in the study, said it provides needed evidence that “there are tools that exist to be able to help meet individuals where they are in the world, and they should be utilized more heavily.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Why the world’s most expensive drug might be worth the price

explore

WSS

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Palantir health business leans on meeting customers’ needs

There's no autism epidemic. It's an autism diagnosis epidemic

There's no autism epidemic. It's an autism diagnosis epidemic

Readout Newsletter: Merck, Vertex, and Viking updates

Why the world’s most expensive drug might be worth the price

explore

fashion

hotspot

Jerome Adams on the need for new antivirals for Covid

Readout Newsletter: Merck, Vertex, and Viking updates

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Medical records are filled with copy

FDA's naming rule on biosimilars has undermined competition

Moonlake's readout produced a cash windfall. Risks remain

Will generative AI in health care meet the fate of IBM's Dr. Watson?

How to save PrEP access — and even expand it

There's no autism epidemic. It's an autism diagnosis epidemic

knowledge

California’s proposed $25 per hour health care minimum wage

Lecanemab for Alzheimer's is coming. Is the health system ready?

Primary care physicians play key roles in Alzheimer's management

Covid vaccine financial winners and losers, from Pfizer to Novavax

Patient advocates debate FDA's accelerated approval process

Will generative AI in health care meet the fate of IBM's Dr. Watson?

explore

entertainment

focus

leisure time